Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance.

Jesus JimenezNicolas KosteleckyJoshua D MitchellKathleen W ZhangChieh-Yu LinDaniel J LenihanKory J Lavine

Published in: Cardio-oncology (London, England) (2023)

While the Dallas criteria can identify a subset of ICI-associated myocarditis patients, quantification of macrophage abundance may expand the diagnostic role of EMB. Failure to meet the traditional Dallas Criteria should not exclude the diagnosis of myocarditis.

Keyphrases

end stage renal disease
adipose tissue
newly diagnosed
ejection fraction
chronic kidney disease
machine learning
peritoneal dialysis
deep learning
antibiotic resistance genes
patient reported outcomes